Related Experiment Video
Updated: Jul 30, 2026

09:03
Trypsin Digest Protocol to Analyze the Retinal Vasculature of a Mouse Model
Published on: June 13, 2013
18.6K
The integrated transcriptome bioinformatics analysis identifies key genes and cellular components for proliferative
Nan Gao1, Shengli Hao1, Guannan Huang1
1Department of Ophthalmology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Plos One
|November 21, 2022
Summary
This study identifies key genes and cellular components involved in Proliferative Diabetic Retinopathy (PDR), a leading cause of blindness. Findings highlight POSTN as a potential therapeutic target for PDR.
Area of Science:
- Ophthalmology
- Genetics
- Bioinformatics
Background:
- Proliferative Diabetic Retinopathy (PDR) is a major cause of blindness linked to diabetes.
- The molecular mechanisms underlying PDR pathogenesis remain incompletely understood.
- RNA sequencing has begun to reveal genes and cellular components involved in PDR.
Purpose of the Study:
- To identify novel target genes and cellular components in Proliferative Diabetic Retinopathy (PDR).
- To elucidate the intrinsic molecular mechanisms of PDR using integrated bioinformatics analysis.
- To discover potential gene signatures and therapeutic targets for PDR.
Main Methods:
- Integrated analysis of two bulk RNA-sequencing and one single-cell RNA-sequencing dataset from PDR patients and controls.
- Identification of differentially expressed genes (DEGs) between PDR and control groups.
- Analysis of ligand-receptor interactions and Protein-Protein Interaction (PPI) networks to identify key proteins.
Main Results:
- 176 differentially expressed genes (DEGs) were identified between PDR patients and controls.
- 14 proteins were found in the overlap of ligand-receptor interactions and PPI networks.
- CD44, ICAM1, and POSTN were identified as PDR-associated proteins, with POSTN potentially acting as a key ligand.
Conclusions:
- This integrated bioinformatics analysis provides novel insights into PDR molecular mechanisms.
- POSTN is highlighted as a potential key ligand and therapeutic target for PDR.
- The identified gene signatures may aid in the future diagnosis and treatment of Proliferative Diabetic Retinopathy.

